Insta
Beating Coronavirus: India’s First Pharma Company BCPL Gets Clearance For Manufacturing Hydroxychloroquine
IANS
Apr 10, 2020, 09:01 PM | Updated 09:01 PM IST
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
Central Public Sector Undertaking Bengal Chemicals and Pharmaceuticals Limited (BCPL) on Friday (10 April) got clearance from drug control authorities to manufacture Hydroxychloroquine, which is being considered effective in treating Covid-19 patients.
The company got the licence days after the union government took the initiative for large-scale manufacture of the drug in view of the raging pandemic.
According to the company chairman P.M. Chandraiya, BCPL has the capability to churn out 10 lakh hydroxychloroquine tablets daily.
Founded in 1901, BCPL is the country's first pharmaceutical company, and once manufactured Hydroychloroquine. However, it stopped manufacturing the product decades back.
Chandraiya said the cost of raw materials for making the drug has gone up 20 times in the past few weeks.
"We have requested the union government to put a cap on the raw material prices," he said.
This news has been published via Syndicate feed. Only the headline has been changed.
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
Introducing ElectionsHQ + 50 Ground Reports Project
The 2024 elections might seem easy to guess, but there are some important questions that shouldn't be missed.
Do freebies still sway voters? Do people prioritise infrastructure when voting? How will Punjab vote?
The answers to these questions provide great insights into where we, as a country, are headed in the years to come.
Swarajya is starting a project with an aim to do 50 solid ground stories and a smart commentary service on WhatsApp, a one-of-a-kind. We'd love your support during this election season.
Click below to contribute.